Cinemark Holdings Inc has a consensus price target of $21.06 based on the ratings of 16 analysts. The high is $27 issued by B. Riley Securities on July 8, 2024. The low is $11 issued by Goldman Sachs on October 11, 2022. The 3 most-recent analyst ratings were released by Morgan Stanley, Macquarie, and B. Riley Securities on July 18, 2024, July 9, 2024, and July 8, 2024, respectively. With an average price target of $25.67 between Morgan Stanley, Macquarie, and B. Riley Securities, there's an implied 20.11% upside for Cinemark Holdings Inc from these most-recent analyst ratings.
1calculated from analyst ratings
Buy Now | Get Alert | |||||||
---|---|---|---|---|---|---|---|---|
07/18/2024 | Buy Now | 21.67% | Morgan Stanley | Benjamin Swinburne | $24 → $26 | Maintains | Overweight | Get Alert |
07/09/2024 | Buy Now | 12.31% | Macquarie | Chad Beynon | $21 → $24 | Maintains | Outperform | Get Alert |
07/08/2024 | Buy Now | 26.35% | B. Riley Securities | Eric Wold | $16 → $27 | Upgrade | Neutral → Buy | Get Alert |
07/01/2024 | Buy Now | 7.63% | Benchmark | Mike Hickey | $23 → $23 | Reiterates | Buy → Buy | Get Alert |
06/27/2024 | Buy Now | 16.99% | Wedbush | Michael Pachter | $25 → $25 | Reiterates | Outperform → Outperform | Get Alert |
06/24/2024 | Buy Now | 21.67% | Roth MKM | Eric Handler | $19 → $26 | Upgrade | Neutral → Buy | Get Alert |
06/17/2024 | Buy Now | 12.31% | Barrington Research | James Goss | $24 → $24 | Maintains | Outperform | Get Alert |
05/06/2024 | Buy Now | 12.31% | Barrington Research | James Goss | $24 → $24 | Reinstates | Outperform → Outperform | Get Alert |
05/03/2024 | Buy Now | 7.63% | Benchmark | Mike Hickey | → $23 | Reiterates | Buy → Buy | Get Alert |
05/03/2024 | Buy Now | -25.13% | B. Riley Securities | Eric Wold | $14 → $16 | Maintains | Neutral | Get Alert |
04/25/2024 | Buy Now | 7.63% | Wedbush | Michael Pachter | → $23 | Reiterates | Outperform → Outperform | Get Alert |
04/22/2024 | Buy Now | 12.31% | Barrington Research | James Goss | $24 → $24 | Reiterates | Outperform → Outperform | Get Alert |
04/18/2024 | Buy Now | 7.63% | Wedbush | Michael Pachter | $20 → $23 | Maintains | Outperform | Get Alert |
04/10/2024 | Buy Now | 2.95% | Benchmark | Mike Hickey | → $22 | Reiterates | Buy → Buy | Get Alert |
04/10/2024 | Buy Now | -11.09% | Roth MKM | Eric Handler | $17 → $19 | Maintains | Neutral | Get Alert |
04/08/2024 | Buy Now | -11.09% | JP Morgan | David Karnovsky | $17 → $19 | Maintains | Neutral | Get Alert |
04/05/2024 | Buy Now | 7.63% | Wells Fargo | Steven Cahall | $13 → $23 | Upgrade | Underweight → Overweight | Get Alert |
04/03/2024 | Buy Now | 2.95% | Benchmark | Mike Hickey | → $22 | Reiterates | Buy → Buy | Get Alert |
02/13/2024 | Buy Now | -6.41% | Wedbush | Alicia Reese | → $20 | Reiterates | Outperform → Outperform | Get Alert |
02/06/2024 | Buy Now | -25.13% | JP Morgan | David Karnovsky | $18 → $16 | Maintains | Neutral | Get Alert |
01/11/2024 | Buy Now | -43.85% | Goldman Sachs | Mike Burton | $16 → $12 | Maintains | Sell | Get Alert |
01/02/2024 | Buy Now | -29.81% | B. Riley Securities | Eric Wold | $23 → $15 | Downgrade | Buy → Neutral | Get Alert |
12/20/2023 | Buy Now | -39.17% | Wells Fargo | Steven Cahall | $16 → $13 | Downgrade | Equal-Weight → Underweight | Get Alert |
10/24/2023 | Buy Now | -25.13% | Wells Fargo | Benjamin Swinburne | $18 → $16 | Maintains | Equal-Weight | Get Alert |
10/06/2023 | Buy Now | 2.95% | Benchmark | Mike Hickey | $21 → $22 | Maintains | Buy | Get Alert |
09/19/2023 | Buy Now | -1.73% | Benchmark | Mike Hickey | → $21 | Reiterates | Buy → Buy | Get Alert |
08/07/2023 | Buy Now | 2.95% | Barrington Research | James Goss | $20 → $22 | Reiterates | Outperform → Outperform | Get Alert |
08/07/2023 | Buy Now | 12.31% | Morgan Stanley | Benjamin Swinburne | $22 → $24 | Maintains | Overweight | Get Alert |
08/07/2023 | Buy Now | -6.41% | Wedbush | Alicia Reese | → $20 | Reiterates | Outperform → Outperform | Get Alert |
08/01/2023 | Buy Now | -6.41% | Wedbush | Alicia Reese | → $20 | Reiterates | Outperform → Outperform | Get Alert |
07/19/2023 | Buy Now | -15.77% | JP Morgan | David Karnovsky | $21 → $18 | Downgrade | Overweight → Neutral | Get Alert |
07/18/2023 | Buy Now | 2.95% | Morgan Stanley | Benjamin Swinburne | $22 → $22 | Reiterates | Overweight → Overweight | Get Alert |
07/12/2023 | Buy Now | -20.45% | Roth MKM | Eric Handler | $18 → $17 | Maintains | Neutral | Get Alert |
07/12/2023 | Buy Now | 7.63% | B. Riley Securities | Eric Wold | $20 → $23 | Upgrade | Neutral → Buy | Get Alert |
07/10/2023 | Buy Now | -11.09% | Benchmark | Mike Hickey | → $19 | Reiterates | Buy → Buy | Get Alert |
06/14/2023 | Buy Now | -6.41% | B. Riley Securities | Eric Wold | $21 → $20 | Downgrade | Buy → Neutral | Get Alert |
05/26/2023 | Buy Now | -11.09% | Benchmark | Mike Hickey | → $19 | Reiterates | Buy → Buy | Get Alert |
05/09/2023 | Buy Now | -6.41% | Barrington Research | James Goss | $19 → $20 | Maintains | Outperform | Get Alert |
05/08/2023 | Buy Now | -1.73% | B. Riley Securities | Eric Wold | $20 → $21 | Maintains | Buy | Get Alert |
05/08/2023 | Buy Now | -6.41% | Macquarie | Chad Beynon | $18 → $20 | Maintains | Outperform | Get Alert |
05/08/2023 | Buy Now | 2.95% | Morgan Stanley | Benjamin Swinburne | $21 → $22 | Maintains | Overweight | Get Alert |
05/08/2023 | Buy Now | -6.41% | Wedbush | Alicia Reese | → $20 | Reiterates | → Outperform | Get Alert |
05/08/2023 | Buy Now | -34.49% | Credit Suisse | Douglas Mitchelson | → $14 | Reiterates | → Neutral | Get Alert |
04/21/2023 | Buy Now | -41.51% | Goldman Sachs | Mike Burton | $11 → $12.5 | Maintains | Sell | Get Alert |
04/17/2023 | Buy Now | -1.73% | Morgan Stanley | Benjamin Swinburne | $16 → $21 | Maintains | Overweight | Get Alert |
04/10/2023 | Buy Now | -6.41% | B. Riley Securities | Eric Wold | $15 → $20 | Maintains | Buy | Get Alert |
04/10/2023 | Buy Now | -20.45% | Benchmark | Mike Hickey | → $17 | Reiterates | → Buy | Get Alert |
04/06/2023 | Buy Now | -34.49% | Credit Suisse | Douglas Mitchelson | $12 → $14 | Maintains | Neutral | Get Alert |
03/28/2023 | Buy Now | -20.45% | Benchmark | Mike Hickey | → $17 | Reiterates | → Buy | Get Alert |
02/27/2023 | Buy Now | -20.45% | JP Morgan | David Karnovsky | $15 → $17 | Maintains | Overweight | Get Alert |
02/27/2023 | Buy Now | -20.45% | Benchmark | Mike Hickey | → $17 | Reiterates | → Buy | Get Alert |
02/27/2023 | Buy Now | -29.81% | B. Riley Securities | Eric Wold | $13 → $15 | Maintains | Buy | Get Alert |
02/27/2023 | Buy Now | -43.85% | Credit Suisse | Douglas Mitchelson | → $12 | Reiterates | → Neutral | Get Alert |
02/23/2023 | Buy Now | -43.85% | Credit Suisse | Douglas Mitchelson | $9 → $12 | Upgrade | Underperform → Neutral | Get Alert |
01/17/2023 | Buy Now | -25.13% | Morgan Stanley | Benjamin Swinburne | → $16 | Reiterates | → Overweight | Get Alert |
01/12/2023 | Buy Now | — | JP Morgan | David Karnovsky | — | Upgrade | Neutral → Overweight | Get Alert |
12/21/2022 | Buy Now | -20.45% | Benchmark | Mike Hickey | $22 → $17 | Maintains | Buy | Get Alert |
11/07/2022 | Buy Now | -29.81% | Wells Fargo | Benjamin Swinburne | $18 → $15 | Maintains | Equal-Weight | Get Alert |
10/27/2022 | Buy Now | -25.13% | Morgan Stanley | Benjamin Swinburne | $22 → $16 | Maintains | Overweight | Get Alert |
10/12/2022 | Buy Now | -57.88% | Credit Suisse | Douglas Mitchelson | $25 → $9 | Downgrade | Outperform → Underperform | Get Alert |
10/11/2022 | Buy Now | -48.53% | Goldman Sachs | Michael Ng | $12.5 → $11 | Maintains | Sell | Get Alert |
10/10/2022 | Buy Now | -29.81% | JP Morgan | David Karnovsky | $19 → $15 | Maintains | Neutral | Get Alert |
08/08/2022 | Buy Now | -15.77% | Wells Fargo | Steven Cahall | $22 → $18 | Maintains | Equal-Weight | Get Alert |
07/19/2022 | Buy Now | 2.95% | Morgan Stanley | Benjamin Swinburne | → $22 | Upgrade | Equal-Weight → Overweight | Get Alert |
06/21/2022 | Buy Now | 7.63% | B. Riley Securities | Eric Wold | $29 → $23 | Maintains | Buy | Get Alert |
04/13/2022 | Buy Now | 35.7% | B. Riley Securities | Eric Wold | $31 → $29 | Maintains | Buy | Get Alert |
03/07/2022 | Buy Now | -36.36% | Goldman Sachs | Michael Ng | $15.4 → $13.6 | Maintains | Sell | Get Alert |
02/28/2022 | Buy Now | 2.95% | Wells Fargo | Steven Cahall | $24 → $22 | Maintains | Equal-Weight | Get Alert |
12/15/2021 | Buy Now | 2.95% | Morgan Stanley | Benjamin Swinburne | — | Maintains | Equal-Weight | Get Alert |
11/09/2021 | Buy Now | 16.99% | Credit Suisse | Meghan Durkin | — | Upgrade | Neutral → Outperform | Get Alert |
10/22/2021 | Buy Now | 2.95% | Wells Fargo | — | — | Initiates | → Equal-Weight | Get Alert |
10/15/2021 | Buy Now | 12.31% | Morgan Stanley | Benjamin Swinburne | — | Maintains | Equal-Weight | Get Alert |
07/29/2021 | Buy Now | -6.41% | Morgan Stanley | Benjamin Swinburne | — | Maintains | Equal-Weight | Get Alert |
The latest price target for Cinemark Hldgs (NYSE:CNK) was reported by Morgan Stanley on July 18, 2024. The analyst firm set a price target for $26.00 expecting CNK to rise to within 12 months (a possible 21.67% upside). 30 analyst firms have reported ratings in the last year.
The latest analyst rating for Cinemark Hldgs (NYSE:CNK) was provided by Morgan Stanley, and Cinemark Hldgs maintained their overweight rating.
The last upgrade for Cinemark Holdings Inc happened on July 8, 2024 when B. Riley Securities raised their price target to $27. B. Riley Securities previously had a neutral for Cinemark Holdings Inc.
The last downgrade for Cinemark Holdings Inc happened on January 2, 2024 when B. Riley Securities changed their price target from $23 to $15 for Cinemark Holdings Inc.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Cinemark Hldgs, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Cinemark Hldgs was filed on July 18, 2024 so you should expect the next rating to be made available sometime around July 18, 2025.
While ratings are subjective and will change, the latest Cinemark Hldgs (CNK) rating was a maintained with a price target of $24.00 to $26.00. The current price Cinemark Hldgs (CNK) is trading at is $21.37, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.